Navigation Links
Amedica Signs Agreement with Kyocera for Commercial Manufacture of Silicon Nitride Medical Devices
Date:11/26/2013

SALT LAKE CITY, Nov. 26, 2013 /PRNewswire/ -- Amedica Corporation, a biomaterials company, today announced a collaboration with Kyocera Industrial Ceramics Corporation, a worldwide leading ceramics producer, to manufacture medical devices from Amedica's Silicon Nitride biomaterial at Kyocera's Vancouver, WA facility. This collaboration includes the manufacture of Amedica's FDA approved Silicon Nitride spinal interbody devices and will broaden Amedica's ability to meet market demand. 

As a biomaterial, Silicon Nitride has been shown to help promote bone growth and has anti-infective properties. Devices made from Silicon Nitride are semi-radiolucent with clearly visible boundaries enabling an exact view of intraoperative placement and postoperative fusion assessment via common imaging modalities. Amedica believes that these are essential characteristics that surgeons seek when choosing the ideal spinal interbody implant for their patients. Amedica has sold over 14,000 of these devices worldwide.

Eric Olson, President and CEO of Amedica Corporation, says, "There is an unmet need for advanced biomaterials in Orthopedics and Spine. We are seeing an increasing interest for our Silicon Nitride interbody devices and increased interest in this material for use in other applications and want to ensure a consistent supply for surgeons and more importantly, patients. As the world's number one producer of advanced ceramics* with vast experience in ensuring market demand is consistently fulfilled for innovative products, Kyocera is the ideal partner to help broaden availability of our novel biomaterial devices."

About Amedica Corporation

Amedica is a commercial biomaterial company focused on using its Silicon Nitride technology platform to develop, manufacture and sell a broad range of medical devices.  Amedica markets spinal fusion products and is developing product candidates for use in total hip and knee joint replacements.  Amedica is a privately owned company founded in 1996. The company operates an ISO 13485 certified manufacturing facility, and, its spine products are FDA cleared, CE marked, and are currently marketed in the US and select markets in Europe and South America. Amedica is based in Salt Lake City, Utah.

About KYOCERA

Kyocera Industrial Ceramics Corporation (www.kyocera.com/kicc), headquartered in Hendersonville, NC, specializes in applying advanced ceramic materials and components to solve the most demanding engineering challenges. It is a wholly-owned subsidiary of Kyocera International, Inc. of San Diego, the North American holding company for Kyocera Corporation.

Kyocera Corporation (NYSE: KYO) (TOKYO: 6971) (http://global.kyocera.com/), the parent and global headquarters of the Kyocera Group, was founded in 1959 as a producer of fine ceramics (also known as "advanced ceramics"). By combining these engineered materials with metals and plastics, and integrating them with other technologies, Kyocera has become a leading supplier of advanced ceramic components, medical products, solar power generating systems, telecommunications equipment, printers, copiers, electronic components, semiconductor packages and cutting tools. During the year ended March 31, 2013, the company's net sales totaled 1.28 trillion yen (approx. USD13.6 billion). The company is ranked #492 on Forbes magazine's 2013 "Global 2000" listing of the world's largest publicly traded companies.

http://www.ceramicindustry.com/articles/93444-ci-top-10-advanced-ceramic-manufacturers

Media Contacts  
Erika Kuzmicz 
Schwartz MSL  
(781) 684-0770  
AMEDICA@schwartzmsl.com

 


'/>"/>
SOURCE Amedica Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Bacterin Signs Distribution Agreement with Jeil for LeForte Craniomaxillofacial System
2. Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA)
3. BioRestorative Therapies Signs Material Manufacturing Agreement With University of Utah
4. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
5. Metamark Genetics Signs Collaboration Agreement on Novel Therapeutic Targets with Janssen Biotech
6. Agendia Signs Contract with Blue Shield of California
7. New England Biolabs Signs Agreement with Synthetic Genomics Inc. to Launch Gibson Assembly™ Master Mix for Molecular and Synthetic Biology Applications
8. Volition Signs Collaboration Agreement With Abcodia
9. MiMedx Signs Agreement with Systagenix for Global Distribution of EpiFix®
10. Psyche Systems Corporation Signs Strategic Alliance with Siemens Healthcare to Provide Anatomic Pathology Solutions
11. IntelliCell BioSciences Signs Technology Licensing Agreement with Stem Cells 21 Thailand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2020)... ... June 25, 2020 , ... Lumeda Inc. ... today announced the company has entered a license agreement with Roswell Park Comprehensive ... globally exclusive rights to Roswell Park intellectual property surrounding a novel medical device ...
(Date:6/23/2020)... ... June 23, 2020 , ... DeCurtis Corporation, the ... today that Derek Fournier has been appointed CEO and President. Founder and former ... immediately. , “DeCurtis Corporation has been on an incredible journey for the ...
(Date:6/23/2020)... ... June 23, 2020 , ... Nobilis Therapeutics, ... that it has filed an Investigational New Drug application (IND) with the U.S. ... its lead drug candidate NBTX-001 in patients with panic disorder (PD). , "Adding ...
(Date:6/11/2020)... , ... June 09, 2020 , ... ... Phase I of a Small Business Innovation Research (SBIR) program funded by the ... Century: Rapid Toxin Detection in the Field”. The project’s goal was to engineer ...
Breaking Biology Technology:
(Date:7/1/2020)... ... July 01, 2020 , ... Catalent, a global leader ... Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in the Shiga prefecture of Japan. ... in Kakegawa, the new 60,000-square-foot facility will provide customers with flexible clinical supply ...
(Date:6/28/2020)... ... 2020 , ... In an upcoming episode scheduled for the fall of 2020, ... solutions (POCT). Check local listings for more info. , Today, the majority of testing ... to labs throughout the country. Results are then available several days later. Now, in ...
(Date:6/23/2020)... KEYNES, England (PRWEB) , ... June 23, 2020 ... ... in Africa supporting sustainable healthcare, and Renovagen Ltd, a UK supplier and manufacturer ... response project to support testing operations in the fight against the COVID-19 pandemic ...
Breaking Biology News(10 mins):